Tarena International, Inc. (NASDAQ:TEDU) shares fell -1.64% in last trading session and ended the day at $8.40. TEDU Gross Margin is 70.80% and its has a return on assets of 9.40%. Tarena International, Inc. (NASDAQ:TEDU) quarterly performance is -13.31%.
Credit Suisse cut shares of Tarena International Inc (NASDAQ:TEDU) from an outperform rating to a neutral rating in a research note published on Thursday, The Fly reports. Credit Suisse currently has $11.00 target price on the stock, down from their previous target price of $13.00.
Peabody Energy Corporation (NYSE:BTU) ended the last trading day at $2.36. Company weekly volatility is calculated as 22.87% and price to cash ratio as 0.13. Peabody Energy Corporation (NYSE:BTU) showed a weekly performance of -48.58%.
Peabody Energy (NYSE:BTU) reported full-year 2015 revenues of $5.61 billion. Adjusted EBITDA totaled $434.6 million, which includes $23.5 million in restructuring charges related to reductions in corporate and regional staff and Australian Mining Operations. Full-year Adjusted EBITDA excludes the impact of $1.28 billion in charges related to asset impairments. Diluted Loss Per Share from Continuing Operations totaled $(102.62) and Adjusted Diluted EPS totaled $(36.39).
On 11 February, Coffee Holding Company, Inc. (NASDAQ:JVA) shares increased 1.32% and was closed at $3.30. JVA EPS growth in last 5 year was -20.30%. Coffee Holding Company, Inc. (NASDAQ:JVA) year to date (YTD) performance is -14.21%.
Coffee Holding Co., Inc. (NASDAQ:JVA) announced that George F. Thomas has joined its Board of Directors (the “Board”), effective February 3, 2016. Mr. Thomas is replacing Robert M. Williams who tendered his resignation to the Board, effective February 3, 2016.
Incyte Corporation (NASDAQ:INCY) shares fell -9.40% in last trading session and ended the day at $65.51. INCY Gross Margin is 96.90% and its has a return on assets of -9.60%. Incyte Corporation (NASDAQ:INCY) quarterly performance is -39.99%.
Incyte Corporation (NASDAQ:INCY) reported Revenues For the quarter ended December 31, 2015, net product revenues of Jakafi were $182 million as compared to $106 million for the same period in 2014, representing 72 percent growth. For the full year ended December 31, 2015, net product revenues of Jakafi were $601 million as compared to $358 million for the same period in 2014, representing 68 percent growth. For the quarter and full year ended December 31, 2015, product royalties from sales of Jakavi outside of the United States received from Novartis were $24 million and $75 million, respectively, as compared to $15 million and $49 million, respectively, for the same periods in 2014.
Cynapsus Therapeutics Inc. (NASDAQ:CYNA) caters to the Healthcare space. Its weekly performance is -5.35%. On the last day of trading company shares ended up at $13.10.
Effective February 1, 2016, Cynapsus Therapeutics Inc. (NASDAQ:CYNA) entered into a lease agreement (the “Lease”) with Richmond Walnut Business Centre Inc. (the “Landlord”), pursuant to which the Company leased the building municipally known as 828 Richmond Street West, in the City of Toronto, Province of Ontario, Canada (the “Property”), including 3,200 square feet on the 1st floor and 3,000 square feet on the lower level, for a combined total useable floor area of 6,200 square feet, together with the shared use of common areas and parking facilities.
Leave a Reply